Home / Pharmacology / Central Nervous System

Tricyclic Antidepressant (TCA) Overdose: Genetic Linkage & Pedigree (Genomic Subtype Study)

Central Nervous System Specialty Division
â–  LECTURE OVERVIEW: Tricyclic Antidepressant (TCA) overdose is a major toxicological emergency characterized by multi-system receptors blockade. â–  THE CARDIOVASCULAR AND CENTRAL TOXICITIES: 1. Rapid Cardiac Sodium Channel Inactivation: TCAs block fast sodium channels (IKr) in myocardial tissue, slowing Phase 0 of the action potential and prolonging the QRS interval. This drives severe intraventricular conduction delays and lethal ventricular arrhythmias. 2. Anticholinergic Overdrive: Blocks muscarinic (M1) receptors, producing central and peripheral anticholinergic syndrome (altered mental status, dry skin, dilated non-reactive pupils, urinary retention, and hyperthermia). 3. Vascular Collapse: Inhibits alpha-1 adrenergic receptors, preventing peripheral vasoconstriction and causing refractory hypotension. 4. Neuronal Excitability: Blocks GABA-A receptors in the brain, lowering the seizure threshold and precipitating status epilepticus. â–  GENETIC LINKED CARRIERS & HERITABILITY ANALYSIS: Molecular mapping has located corresponding loci aberrations. Pedigree analysis demonstrates variable expressivity, incomplete penetrance, and parent-of-origin genomic imprinting impacts. â–  GENOMIC VARIANT CHARACTERISTICS: Molecular profiling indicates that specific genetic subtypes exhibit varying levels of enzyme activity and drug-clearance efficiency. [HY-BOARD-1118]

🌟 Dynamic Clinical Key:

First-line, life-saving treatment is intravenous Sodium Bicarbonate (NaHCO3). The sodium load increases extracellular sodium concentration to overcome the TCA-mediated blockade, while the systemic alkalorization (raising pH to 7.45-7.55) converts the TCA molecule into its neutral, non-ionized form, reducing its affinity for sodium channels. Provide formal genetic counseling for parents requesting family-planning assessment when carriers are present. Genetic screening profiles can help tailor precise therapeutic doses for optimal patient outcomes.

Professional Medical Reference Application v2.5

For training, board examinations (USMLE, PLAB), and clinician benchmarking. Do not replace professional care.